(Q70156002)
Statements
Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01 (English)
H M Vriesendorp
J M Herpst
M A Germack
J L Klein
P K Leichner
D M Loudenslager